Last reviewed · How we verify

NCT05804630

Efficacy and Safety of Articaine and Lidocaine in Extraction of Wisdom Teeth of Upper and Lower Jaws

Status unknown NA Last updated 7 April 2023
What this trial tests

NA trial testing Different dental anesthetic agents during wisdom tooth surgery (Orabloc®, Octocaine®, and Xylestesin-A®) in Wisdom Tooth in 60 participants. Status unknown.

Timeline
15 March 2023
Primary endpoint
31 January 2024
31 July 2024

Quick facts

Lead sponsorNational Taiwan University Hospital
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposetreatment
Enrollment60
Start date15 March 2023
Primary completion31 January 2024
Estimated completion31 July 2024
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

National Taiwan University Hospital

Who can join

Adults 20 to 60, any sex, with Wisdom Tooth or Dental Impaction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Local anesthesia drugs and anesthesia technique play an imperative role in dental treatment. The purpose of this study was to compare the efficacy and safety of different dental local anesthetics drugs and brands in clinical use for the extraction of wisdom teeth.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Efficacy and safety of infiltration anesthesia with 4 % Articaine and block anesthesia with 2 % Lidocaine in the mandibular third molar extraction.
    Huang NC, Chang HH, Lin CP. · · 2025 · PMID 40224063 · DOI 10.1016/j.jds.2025.01.018

Verify or expand the search:

Other National Taiwan University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05804630.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing